4//SEC Filing
Echelard Yann 4
Accession 0001437749-25-020546
CIK 0001001316other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 5:47 PM ET
Size
6.9 KB
Accession
0001437749-25-020546
Insider Transaction Report
Form 4
Echelard Yann
Director
Transactions
- Sale
Common Stock
2025-06-13$36.94/sh−10,000$369,400→ 228,816 total - Award
Common Stock
2025-06-12+14,718→ 238,816 total
Footnotes (4)
- [F1]Reflects a grant of restricted shares that will vest on June 12, 2026.
- [F2]Includes shares of restricted Common Stock, which vest over various time periods.
- [F3]These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Echelard's income tax obligations.
- [F4]Includes a weighted average price for shares sold in multiple transactions at prices ranging from $36.93 through $36.96, inclusive. Mr. Echelard undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
TG THERAPEUTICS, INC.
CIK 0001001316
Entity typeother
Related Parties
1- filerCIK 0001561958
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 5:47 PM ET
- Size
- 6.9 KB